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The low energy collision induced dissociation (CID) of the carboxylate anions generated by 
electrospray ionization of leukotriene B, (LTB,) and 16 of its metabolites was studied in a 
tandem quadrupole mass spectrometer. LTB, is a biologically active lipid mediator whose 
activity is terminated by metabolism into a wide variety of structural variants. The collision- 
induced dissociation spectra of the carboxylate anions revealed structurally informative ions 
whose formation was determined by the position of hydroxyl substituents and double bonds 
present in the LTB, metabolite. Major ions resulted from charge remote ol-hydroxy fragmen- 
tation or charge directed a-hydroxy fragmentation. The conjugated triene moiety present in 
some metabolites was proposed to undergo cyclization to a 13-cyclohexadiene structure 
prior to charge remote or charge driven a-hydroxy fragmentation. The mechanisms responsi- 
ble for all major ions observed in the CID spectra were studied using stable isotope labeled 
analogs of the LTB, metabolites. In general, the collision-induced decomposition of carboxyl- 
ate anions produced unique spectra for all LTB, derived metabolites. The observed decom- 
position product ions from the carboxylate anion could be useful in developing assays for 
these molecules in biological fluids. (I Am Sot Mass Spectrom 2996, 7, 229-139) 
L eukotriene B, [5(SJ,12(R)-dihydroxy6(Z),8( E), lO(E),14(Z)-eicosatetraenoic acid (LTB,)] is a po- tent neutrophil chemotactic agent produced from 
arachidonic acid that follows activation of 5-lipoxy- 
genase with the intermediate formation of leukotriene 
A, and hydrolysis catalyzed by LTA, hydrolase [l, 21. 
The bioactivity of this important lipid mediator is 
terminated rapidly by metabolism that involves sev- 
eral pathways unique to LTB, and also by pathways of 
normal fatty acid metabolism. Elucidation of these 
metabolic processes has resulted from the identifica- 
tion of numerous LTB,-derived metabolites. 
The first LTB, metabolic pathway identified was 
*oxidation in human polymorphonuclear leukocytes 
that resulted in formation of 20-hydroxy-LTB, (20-OH- 
LTB,) 131 and involved the activity of a specific cy- 
tochrome P-450,,,, [4]. This *oxidized product re- 
tains substantial bioactivity and is further metabolized 
to 20-carboxy-LTB, (20-COOH-LTB,) 15, 61. Formation 
of these metabolites also has been identified in isolated 
rat hepatocytes [71 and rat hepatic cell preparations [8, 
91. Further metabolism of 20-COOH-LTB, by P-oxida- 
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tion results in formation of 18-COOH-LTB, and 16- 
COOH-LTB, [7, lo]. 
Metabolism of LTB, by reduction of the 10,ll dou- 
ble bond of the conjugated triene system has been 
reported in several cell types that do not metabolize 
LTB, by *oxidation [ll, 121. This metabolism involves 
the intermediate formation of 12-oxo-LTB, and lO,ll- 
dihydro-12-oxo-LTB, [131. Reduction of the 10,ll dou- 
ble bond also has been observed in conjunction with 
reduction of the 14,15 double bond that results in 
formation of 10,11,14,15-tetrahydro-12-oxo-LTB, [14] 
and 10,11,14,15-tetrahydro-LTB, (5,12-dihydroxy-6,8- 
eicosadienoic acid; unpublished results from LTB, 
metabolism in perisinusoidal stellate cells). AItema- 
tively, reduction of the 14,15 double bond may occur 
without reduction of the 10,ll double bond that results 
in formation of 14,15-dihydro-LTB, (unpublished re- 
sults from LTB, metabolism in RAW 264 cells, a 
macrophage cell line). 
Metabolism of LTB, by carboxy-terminus P-oxida- 
tion to form 3-OH-LTB, (3,5,12-trihydroxy-6,8,10,14- 
eicosatetraenoic acid) has been reported in isolated rat 
hepatocytes in the presence of ethanol [15] and in 
human-derived hepatoma Hep G2 cells [16]. Further 
P-oxidation at the carboxy terminus has been sug- 
gested to result in the chain-shortened metabolite lo- 
hydroxy4,6,8,12-octadecatetraenoic acid [16,17]. Com- 
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bination of metabolism by double bond reduction and 
carboxy-terminus P-oxidation may result in the re- 
duced metabolites lO,ll-dihydro-3-OH-LTB, and lo- 
hydroxy4,6,12-octadecatrienoic acid [16, 181. 
Finally, LTB, metabolism also may result in the 
formation of glutathione conjugates [18]. In this path- 
way, 12-0x0-LTB, is the likely substrate for a Michael- 
type addition of the tripeptide moiety that yields a 
metabolite that is a peptidolipid. 
Identification of these metabolites has required ini- 
tial purification from sample matrix, usually by solid 
phase extraction and reverse phase high-performance 
liquid chromatography (HPLC) analysis. Structural 
characterization of purified metabolites has been 
achieved by a variety of mass spectrometric methods 
that include gas chromatography-mass spectrometry 
(GC/MS) analysis in both positive and negative ion 
modes [11-181, which require prior derivatization, and 
by high energy and low energy fast-atom bombard- 
ment tandem mass spectrometry (FAB-MS/MS) analy- 
sis [18, 191. For complete structural characterization of 
some metabolites, additional chemical modifications 
were necessary. These modifications include hydra 
genation followed by GC/MS analysis to determine 
location of hydroxy substituents and ozonolysis fol- 
lowed by GC/MS analysis, which established double 
bond location in metabolites of the lO,ll-reductase 
pathway. Presently, no single analytical tool that iden- 
tifies all LTB, metabolites has been used. 
The present study examines the use of negative ion 
electrospray ionization (ES0 tandem mass spectrome- 
try for the complete structural characterization of the 
many LTB, metabolites. Formation of product ions 
after collision-induced decomposition of the [M - HI- 
ion provided unique spectra for each metabolite. De- 
composition mechanisms also have been studied by 
the use of stable isotope-labeled analogs and generally 
can be described by mechanisms previously proposed 
for the decomposition of monohydroxy unsaturated 
fatty acids [20]. 
Methods 
Leukotriene B, was obtained from Biomol Research 
Laboratories (Plymouth, PA). 5-Trans-LTB,, 12-epi-6- 
trans-LTB, and 5,12-diHETE were obtained from Cay- 
man Chemical (Ann Arbor, MI). All LTB,-derived and 
6-fmns-LTB,-derived metabolites were obtained from 
metabolism studies with Hep G2 cells, Ito cells, human 
keratinocytes, and rat hepatocytes. These metabolites 
were purified and structurally characterized as previ- 
ously described [181. Metabolites were dissolved in 
methanol:water (1: 11 at l-4 rig/FL for analysis by 
negative ion electrospray ionization mass spectrometry 
(ESI/MS). Samples (l-5 FL) were introduced into a 
Sciex API III+ triple quadrupole mass spectrometer 
WE-Sciex, Thornhill, Ontario, Canada) by flow injec- 
tion through a 0.5-m X 50-km fused silica capillary 
with methanol:water (1: 11 as the mobile phase at a 
flow rate of 10 kL/min. Spectra were acquired at 
3 s/scan over the mass range m/z 50 to 500 for most 
metabolites; the mass range was extended to m/z 700 
for glutathione-containing metabolites. A spray volt- 
age of -2400 V was used with an orifice voltage of 
-60 V and a collisional offset potential of 20 eV. 
Collision-induced dissociation (CID) spectra were ob- 
tamed with a pressure of argon in the second 
quadrupole equivalent to 200 x 10” molecules/cm*. 
This resulted in a 40-80% reduction in the precursor 
ion for most metabolites. Deuterium exchange of labile 
hydroxy and carboxy protons was performed by dis- 
solving the sample in lOO-ILL MeOD, evaporating un- 
der N,, and redissolving the sample in MEOD:D,O 
(1 : 1). These samples were analyzed by using 
MeOD:D,O (1: 1) as the mobile phase. Exchange of 
carboxylate oxygens with is0 was performed by treat- 
ment of the dried samples with 50 units of porcine 
liver esterase in lOO-PL H2i80 for 2 h at 37°C [21]. 
Samples were acidified with formic acid and extracted 
twice with ethyl acetate. The combined ethyl acetate 
extracts were dried under N, and dissolved in 
methanol:water (1 : 1) for ES1 analysis. 
Results and Discussion 
Negative ion ESI/MS of all LTB,-derived metabolites 
produced abundant carboxylate anions. Generally, the 
most abundant ion produced by collision-induced dis- 
sociation of the [M - HI- anions resulted from (Y- 
hydroxy fragmentation. Fragmentation mechanisms 
previously described for CID processes that involve 
monohydroxy unsaturated fatty acid anions described 
a-hydroxy fragmentation by either charge-remote or 
charge-directed mechanisms [20]. The charge-remote 
process requires a double bond two carbons removed 
from the hydroxy-substituted carbon with fragmenta- 
tion that results in formation of an aldehyde moiety 
and a terminal alkene after hydroxy proton transfer 
(Scheme I). 
This type of fragmentation for compounds that con- 
tain a double bond one carbon removed from the 
hydroxy-substituted carbon (an apparent vinylic frag- 
mentation) also was observed and suggested to occur 
after double bond rearrangement. The charge-directed 
process also requires a double bond two carbons re- 
moved from the hydroxy-substituted carbon, or 
rearrangement of double bonds to this position, with 
fragmentation that results in formation of a terminal 
Scheme I. Charge-remote a-hydroxy fragmentation. 
R’ _ ,j + JR’ 
Scheme II. Charge-directed a-hydroxy fragmentation. 
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aldehyde and a charge-stabilized allylic anion (Scheme 
II). These mechanisms also may describe the fragmen- 
tation processes after CID of the LTB,-derived metabo- 
lites. However competing mechanisms that do not 
involve a-hydroxy fragmentation also were observed. 
LTB, (Figure IA) 
Collision-induced dissociation of the [M - HI- ion of 
LTB, produced ions that resulted from loss of H,O 
(m/z 317) and loss of 2H,O (nz/z 2991, with addi- 
tional losses of CO, from the dehydrated ions to pro- 
duce ions at 111/z 273 and 255. An abundant ion at 
nr/z 195, which was shifted to t~/z 197 in the CID 
spectrum of d,-OD-LTB, and to N/Z 199 in the CID 
spectrum of [‘80,]-LTB,, was consistent with cx- 
hydroxy charge-directed fragmentation of the C-ll,C- 
12 bond-an apparent vinylic position. A possible 
mechanism for the formation of this ion involves initial 
rearrangement of the conjugated triene system to a 
cyclohexadiene structure followed by C-12 alkoxide 
abstraction of the C-5 proton. This results in an ion 
structure that is a tautomer of a 5-0~0 structure 
(Scheme III, Structure 11 and has the charge site delo- 
calized by resonance over seven carbon atoms. 
Charge-directed fragmentation initiated by the C-12 
alkoxide ion then results in loss of a neutral terminal 
aldehyde and the observed ion. Thermal rearrange 
ment of the conjugated triene moiety to a cyclohexa- 
diene structure was observed previously in GC/MS 
analysis of derivatized 5,12-diHETE and required the 
specific trans, cis, trans double bond geometry [22, 231. 
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Figure 1. Negative ion ES1 tandem mass spectrometry product 
ion spectra of (A) Leukotriene B, ([M - HI-, nr/z 335) and (B) 
14,15-dihydro-LTB, ([M - HI-, 111/z 337). 
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Scheme III 
In the present study, analysis of 5,12-diHETE, 6-trans- 
LTB,, and 12-epi-6-trans-LTB, produced spectra iden- 
tical to that of LTB, (data not shown), which suggests 
that neither initial double bond stereochemistry nor 
chirality affect fragmentation. Decarboxylation of m/z 
195 (loss of 44 u) would produce the ion at m/z 151, 
which also retained two deuteriums in the CID spec- 
trum of ds-OD-LTB, (m/z 1531, but was unchanged in 
the CID spectrum of [“O,]-LTB, consistent with loss 
of CO,. Loss of CO, and ethylene (28 u) from m/z 195 
as the 5-0~0 structure would result in the ion observed 
at m/z 123. This ion was observed at m/z 125 in the 
CID spectrum of d,-OD-LTB, and was unchanged in 
the CID spectrum of [‘80,]-LTB,. A possible charge- 
remote mechanism for the formation of this ion with 
retention of two deuterium atoms is shown in Scheme 
IV; however, other charge-directed mechanisms are 
possible also. 
Formation of N/Z 195 also could be described by a 
charge-remote mechanism that involves transfer of the 
C-12 hydroxy proton to the cyclohexadiene structure. 
However, the extended conjugation that involves the 
C-5 enolate structure produced a more stabilized anion 
compared to localization of the charge site at the car- 
boxy terminus. In addition, formation of a C-5 0x0 or 
enolate structure more readily accounted for formation 
of the lesser abundant ions. 
With charge localized as the carboxylate anion in 
the cyclohexadiene structure, dehydration that in- 
volves the C-12 hydroxy substituent and the C-5 pro- 
_\ \ \ ~0b4~~) 
OH(D) 
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Scheme IV 
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ton would result in an extended conjugated enolate 
structure that also could tautomerize to a 5-0~0 struc- 
ture (Scheme V, Structure 21. Fragmentation initiated 
by proton abstraction at the C-4 position by the car- 
boxylate ion would result in loss of a neutral ketene 
moiety and formation of the ion at m/z 203, which is 
stabilized by the conjugated triene structure (Scheme 
V, pathway A). Consistent with this mechanism, this 
ion was observed at m/z 204 in the CID spectrum of 
the deuterated analog and was unchanged in the spec- 
trum of [isO,]-LTB,. Alternatively, rearrangement of 
the conjugated triene moiety in Structure 2 to a cyclo- 
hexadiene structure followed by transfer of the C-12 
proton to the 5-0~0 substituent would result in loss of 
a neutral-substituted benzene and formation of the ion 
at m/z 129 (Scheme V, pathway Bl. This ion was 
shifted to m/z 130 in the CID spectrum of d,-OD-LTB, 
and was observed at m/z 133 in the CID spectrum of 
[“O,]-LTB, consistent with retention of the carboxyl- 
ate moiety. Formation of m/z 129 by the mechanism 
shown in Scheme V, pathway B, was suggested previ- 
ously to account for the observation of this ion in the 
CID spectrum of the [M - HI- ion of 5-oxo-eico- 
sa tetraenoic acid [ 241. 
The ion at m/z 245 was shifted to m/z 247 in the 
CID spectrum of da-OD-LTB, and was unchanged in 
the CID spectrum of [“O,]-LTB,. This was consistent 
with C-3,C4 fragmentation via a mechanism analo- 
gous to formation of m/z 123 (Scheme IV> from the 
enolate form of Structure 1 after dehydration of the 
C-12 hydroxy substituent to form a double bond at 
C-12,C-13. 
Low mass fragment ions at m/z 59 and 71 were not 
shifted in the CID spectrum of da-OD-LTB,, but both 
were shifted by 4 u to m/z 63 and 75, respectively, in 
the CID spectrum of [i80,]-LTB,. A portable mecha- 
nism that leads to the formation of m/z 59 would 
involve C-4 proton abstraction by the carboxylate moi- 
ety and subsequent loss of a neutral terminal alkene 
and formation of acetic acid enolate anion (Scheme VI). 
This anion may rearrange to the isomeric acetate anion 
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[25, 261. Formation of m/z 71 may involve dehydra- 
tion of the C-5 hydroxy substituent by proton transfer 
from C-2 with loss of a neutral terminal alkene and 
formation of ionized 2-propenoic acid (Scheme VII). 
14,15-Dihydro-LTB, (Figure 1 B) 
Collision-induced dissociation of the carboxylate ion of 
14,15-dihydro-LTB, resulted in ions formed due to loss 
of Hz0 (m/z 3191, loss of Hz0 and CO, (m/z 275), 
and loss of 2HzO (m/z 301). Fragmentation of the 
carbon skeleton resulted in several ions identical to the 
fragment ions observed for LTB, and were consistent 
with the lack of involvement of the C-14 double bond 
in fragmentation. Fragment ions that contain the methyl 
terminus at m/z 205 and 247 were shifted appropri- 
ately by 2 u from those observed in LTB,. The ion at 
m/z 177 also was observed as a low abundance ion in 
the CID spectrum of LTB,, where it was observed at 
m/z 178 in the deuterated analog and at m/z 179 in 
the “0, analog. This was consistent with loss of water 
from m/z 195 at the carboxylic acid moiety, which 
accounts for loss of one “0, with formation of a ketene 
structure. 
20-OH-LTB, , 2O-COOKLTB,, and 
16-COOH-LTB, (Figure 2) 
Modification by the addition of the hydroxy sub- 
stituent at C-20 in 20-OH-LTB, had no affect on frag- 
mentation pathways in the CID analysis of this 
metabolite with major fragment ions observed as iden- 
tical to those in LTB,. Ions at m/z 219 and 261, 
analogous to m/z 203 and 245 in LTB,, reflect the 
presence of the additional oxygen in the methyl ter- 
minus. 
Ions that resulted from fragmentations identical to 
those of LTB, also were observed in the CID spectrum 
of 20-COOH-LTB, (Figure 28). In addition, abundant 
ions were observed that resulted from localization of 
the charge site as the C-20 carboxylate ion. The ion at 
m/z 141 likely is formed by charge-remote fragmenta- 
tion that involves transfer of the C-12 hydroxy proton 
to C-15 followed by loss of the neutral aldehyde (C-l 
through C-12) and formation of the observed terminal 
R% + H2O + f 
co; 
m/z 71 
Scheme V Scheme VII 
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Figure 2. Negative ion ES1 tandem mass spectrometry product 
ion spectra of (A) 20-hydroxy-LTB, ([M - HI-, w/z 351), (B) 
20-carboxy-LTB, ([M - HI-, VI/Z 365), and (C) 16-carboxy-LTB, 
([M - HI-, m/z 311). 
alkene C-20 carboxylate ion. The ion at m/z 169 also 
may be formed by a charge-remote fragmentation that 
involves C-12 hydroxy proton transfer to C-9 in the 
rearranged cyclohexadiene structure. Fragmentation of 
the C-ll,C-12 bond then results in the observed termi- 
nal aldehyde that contains the C-20 carboxylate anion. 
CID of the carboxylate ion of 16-COOH-LTB, (m/z 
311) resulted in prominent fragment ions at m/z 195, 
177, and 129 identical to LTB, (Figure 2C). Except for 
initial double bond stereochemistry, this is a palin- 
dromic compound, and the fragmentation mechanisms 
described for LTB, would result in identical ions with 
the charge site localized as either the C-l carboxylate 
ion or the C-16 carboxylate ion. An abundant ion at 
m/z 115 was observed that corresponds to fragmenta- 
tion of the C-5,C-6 bond with charge at C-l or the 
C-ll,C-12 bond with charge at C-16. Formation of this 
ion may involve the intermediate formation of the 
cyclohexadiene structure followed by hydroxy proton 
transfer in a charge-remote process that results in for- 
mation of a terminal aldehyde that contains the car- 
boxylate moiety. 
lo,1 1 -Dihydro-LTB,, 6,7-Dihydro-LTB,, and 
lo,1 2,14,15-Tetrahydro-LTB, (Figure 3) 
The major fragment ion observed in the CID spectrum 
of lO,ll-dihydro-LTB, (5,12-dihydroxy-6,8,14- 
eicosatrienoic acid; m/z 115; Figure 3A), was consis- 
tent with charge-remote fragmentation of the C-5,C-6 
bond that involved a proton transfer. This bond is at 
an apparent vinylic position and fragmentation may 
involve rearrangement of the conjugated diene by a 
hydrogen transfer to form a C-7,C-9 conjugated diene 
(Scheme VIII) as has been proposed for the rearrange 
ment of the conjugated diene in monohydroxy 
J I ‘35 139 I1.I 163 179197 ,I 203 25s ,257 301 I 319 ( 
loo IS0 200 25-o 300 
m/Z 
115 
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Figure 3. Negative ion ES1 tandem mass spectrometry product 
ion spectra of (A) lO,ll-dihydro-LTB, ([M - HI-, m/z 3371, (B) 
6,7-dihydro-LTB, ([M - HI-, m/z 337), and (C) 10,11,14,15- 
tetrahydro-LTB, ([M - HI-, m/z 339). 
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Scheme VIII 
eicosatetraenoic acids [20]. Charge-remote fragmenta- 
tion with transfer of the C-5 hydroxy proton to C-8 
would result in the C-5 terminal aldehyde that con- 
tains the C-l carboxylate anion at m/z 115 (Scheme 
VIII, pathway A). Consistent with this mechanism, this 
ion was also the base peak in the CID spectrum of 
d,-OD-lO,ll-dihydro-LTB, and was observed at m/r 
119 in the CID spectrum of [180,]-10,11-dihydro-LTB4. 
A less abundant ion at m/z 116 (15%) in the CID 
spectrum of d,-OD-lO,ll-dihydro-LTB, may imply 
transfer of the C-4 proton to C-8 with fragmentation 
that results in a terminal enolized aldehyde, which 
would retain one deuterium (Scheme VIII, pathway B). 
Charge-remote fragmentation of the C-12,C-13 bond 
with a proton transfer to C-15 resulted in an observed 
ion at m/z 225 that was shifted to m/z 229 when 
[1802]-10,11-dihydro-LTB, was analyzed. This ion was 
shifted to both m/z 226 (4%) and m/z 227 (8% in the 
CID spectrum of da-OD-lO,ll-dihydro-LTB,, which 
implies competitive mechanisms of proton transfers 
that involve either the C-12 hydroxy proton or a pro- 
ton at C-11, analogous to Scheme VIII. The ion ob- 
served at m/z 179, which shifted to m/z 183 for 
[‘802]-10,11-dihydro-LTB,, may result from initial de- 
hydration of the C-5 hydroxy substituent that involves 
abstraction of the C-10 proton and formation of a 
conjugated triene system (Scheme IX). Charge-directed 
fragmentation of the C-ll,C-12 bond would result in 
loss of a neutral terminal aldehyde with formation of 
the observed stabilized ion, which retained one deu- 
terium in the CID spectrum of d,-OD-lO,ll-dihydro- 
LTB,. 
m/z 179(180) 
m/z301 
m/z203 
Scheme X 
Due to rearrangement of the conjugated diene sys- 
tem, an almost identical spectrum was obtained from 
CID of the carboxylate ion of 6,7-dihydro-LTB, (Figure 
3B), a compound which has been identified as a 
metabolite of 6-trans-LTB, [27]. One distinguishing ion 
was observed at m/r 203. This ion may be formed by 
dehydration of the C-12 hydroxy substituent (m/z 
319) followed by charge-directed fragmentation of the 
C-5,C-6 bond (Scheme X), analogous to formation of 
m/z 179 from lO,ll-dihydro-LTB,. An apparent com- 
petitive reaction of this ion (m/z 319) would be fur- 
ther loss of water to form a conjugated tetraene carbox- 
ylate anion at 7n/z 301. 
Collisional activation of the carboxylate ion of 
10,11,14,15-tetrahydro-LTB, (m/z 3391 resulted in ob- 
served ions at W/Z 115 and 179 (Figure 3C), which 
would be consistent with fragmentations identical to 
that of lO,ll-dihydro-LTB,. Fragmentation of the C- 
12,C-13 bond, which resulted in an observed ion at 
m/z 225 for lO,ll-dihydro-LTB,, was not observed for 
the tetrahydro analog, consistent with involvement of 
the C-14 double bond in dihydro-LTB, in this frag- 
mentation. The ion observed at m/z 141 likely in- 
volved C-ll,C-12 bond fragmentation and a proton 
transfer with charge localized as the C-12 alkoxide ion. 
The mechanism for this fragmentation would require 
prior double bond rearrangement to a C-7,C-9 conju- 
gated diene followed by charge-remote C-13 proton 
transfer to C-9 and cleavage of C-ll,C-12 that resulted 
in a stabilized alkoxide ion (Scheme XI). The corre- 
sponding fragmentation also was observed for 10,11- 
dihydro-LTB,. An observed ion at m/t 139 reflects the 
additional unsaturation at C-14 and was not shifted in 
the CID spectrum of da-OD-lO,ll-dihydro-LTB, or 
I OH m/z339 
0- 
m/z141 
Scheme IX Scheme XI 
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[‘sO,]-lO,ll-dihydro-LTB,. The ion at m/z 267 was 
consistent with C-3,C-4 bond fragmentation and was 
observed at low abundance for lO,ll-dihydro-LTB, at 
m/z 265. 
12-0x0-LTB,, lo,1 1 -Dihydro-l2-Oxo-LTB, , and 
10,Z 1,14,15-Tetrahydro-12-Oxo-LTB, (Figure 4) 
CID of the carboxylate ion of the 12-0~0 metabolites 
resulted in loss of H,O (18 u) and loss of H,O and 
CO, (loss of 62 u) for each metabolite. Product ions 
that follow CID of the carboxylate ion of 12-oxo-LTB, 
(Figure 4A), which did not contain the carboxy termi- 
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Figure 4. Negative ion ES1 tandem mass spectrometry product 
ion spectra of (A) lZ-OXO-LTBJ ([M - HI-, ~I/Z 3331, (B) 10,11- 
dihydro-12-oxo-LTB, ([M - HI-, m/z 335), and (C) 10,11,14,15- 
tetrahydro-12-oxo-LTB, ([M - HI-, ?U/Z 337). 
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m/z 179 
nus as evidenced by analysis of [‘so,]-12-oxo-LTB,, 
were observed at m/z 219, 179, and 153. These ions 
may be formed by initial oxidation of the C-5 hydroxy 
substituent via intermediate formation of the cyclo- 
hexadiene structure (Scheme XII). This would result in 
enolate structures at both C-5 and C-12. 
Abstraction of the C-4 proton by the carboxylate ion 
would result in loss of a neutral ketene and formation 
of the stabilized ion at m/z 219. Further losses of 
cyclopropene or cyclopentadiene would result in ions 
at m/t 179 and 153, respectively. These reactions are 
plausible but have not been proven. Similar rearrange- 
ment reactions that involve cyclization due to nucle- 
ophihc attack by a carbanion on unsaturated systems 
have been reported [28]. These ions also were present 
in the CID spectrum of lO,ll-dihydro-12-oxo-LTB, 
(Figure 4B), where they may be formed by initial 
double bond rearrangement followed by loss of a neu- 
tral enolate rather than loss of ketene to form m/z 219 
(Scheme XIII). These ions are shifted by 2 u in the CID 
0 
R 
OH 
double bond rearrangement 
0 
Rh 
\\ -zR 
m/z 219 
Scheme XIII 
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spectrum of 10,11,14,15-tetrahydro-12-oxo-LTB,, con- 
sistent with saturation of the C-14 double bond (Fig- 
ure 40. 
The ion at m/z 179 in the spectrum of 12-oxo-LTB, 
(Figure 4A) w as observed at both m/z 179 (83%), 
consistent with the preceding mechanism, and at m/z 
183 (100%) in the CID spectrum of [‘80,1-12-oxo-LTB,. 
This was not the case for the dihydro analogs where 
m/z 179 (lO,ll-dihydro-12-oxo-LTB,) and the corre- 
sponding ion in the tetrahydro-12-oxo metabolite (m/z 
181) showed no contribution from the carboxylate moi- 
ety in the CID spectra of the [“O,] analogs. Formation 
of the ion that contains the carboxy terminus is consis- 
tent with fragmentation of the C-lO,C-11 double bond 
and transfer of two hydrogens. This may involve inter- 
mediate formation of enolate structures at both C-5 
and C-12. 
Other ions unique to 12-oxo-LTB, include m/z 203, 
which may have the structure shown in Scheme V and 
was not changed in [ ‘80,]-12-oxo-LTB,, and m/z 155, 
which was shifted to m/z 159 in the “0, analog, 
which suggests fragmentation of the C-8,C-9 double 
bond. Mechanisms for the formation of both of these 
ions also may involve intermediate formation of a 
5-0~0 structure. The ion at m/z 129, which was shifted 
to m/z 133 in the CID spectrum of [‘80,]-12-oxo-LTB,, 
also was observed in the CID spectra of both dihydro- 
12-0x0-LTB, and tetrahydro-lZoxo-LTB,. Formation 
of this ion also may involve the intermediate formation 
of a 5-0~0 structure as shown in Scheme V for LTB,. 
A distinguishing fragment ion of lO,ll-dihydro-12- 
oxo-LTB, at m/z 115, which was shifted to m/r 119 in 
analysis of [‘80,]-10,11-dihydro-12-oxo-LTB,,, likely is 
formed by fragmentation of the C-5,C-6 bond after 
double bond rearrangement as observed for lO,ll- 
dihydro-LTB, (Scheme VIII). This ion also was ob- 
served in 10,11,14,15-tetrahydro-l2-oxo-LTB, (Fig- 
ure 40. 
3-OH-20,ll -Dihydro-LTB, and 3-OH-LTB, 
(Figure 5) 
Introduction of an additional hydroxy substituent at 
C-3 resulted in a change in the fragmentation pattern 
for CID of 3-OH-lO,ll-dihydro-LTB, and 3-OH-LTB, 
away from a-hydroxy fragmentation, which resulted 
in ions at m/z 115 or 195, to cY-hydroxy fragmentation, 
which resulted in loss of the first four carbons. The 
only significant high mass ion observed in the CID 
spectrum of 3-OH-lO,ll-dihydro-LTB, anion (m/z 249; 
Figure 5A) was consistent with charge-remote frag- 
mentation of the C-4,C-5 bond with charge localized as 
the C-12 alkoxide ion. Transfer of the C-5 hydroxy 
proton to the 3-OH substituent and subsequent loss of 
H,O and 3-butenoic acid (104 u) would result in for- 
mation of the observed ion at m/z 249 (Scheme XIV). 
The CID spectrum of 3-OH-LTB, (Figure 5B) shows an 
additional fragmentation after loss of 104 u. This 
metabolite contains the 3-OH-1,5-diene moiety re- 
b 
IO0 
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Figure 5. Negative ion ES1 tandem mass spectrometry product 
ion spectra of (A) 3-hydroxy-lO,ll-dihydro-LTB4 ([M - HI-, m/z 
353) and (B) 3-hydroxy-LTB, ([M - HI-, IV/Z 351). 
quired for an oxy-Cope rearrangement (C-10 through 
C-14). This rearrangement previously was proposed to 
account for the formation of odd electron ions that 
followed CID of monohydroxy fatty acids [20]. An 
oxyCope rearrangement of the proposed structure that 
corresponds to [(M - 1) - 1041 for 3-OH-LTB, fol- 
lowed by homolytic bond fragmentation would result 
in the odd electron ion at m/z 136 (Scheme XV). 
Consistent with this mechanism, m/z 136 was not 
shifted in the CID spectrum of d,-OD3-OH-LTB,. An 
abundant ion at m/z 271 may result from loss of 
2H,O and CO,, which results in an ion stabilized by 
extended conjugation. This is not as favorable a pro- 
cess for the lO,ll-dihydro analog due to interruption of 
the conjugated system. 
ZO-OH-4,6,8,12-Octadecatetraenoic Acid 
(ZO-HOTE) and ZO-OH-4,6,12-Octadecatrienoic 
Acid (lo-HOTrE) (Figure 6) 
Collisional activation of the carboxylate ion derived 
from lo-HOE (m/z 291) resulted in formation of an 
abundant ion at m/z 135, and CID of the carboxylate 
0- 
fl-- e + Hz0 + -C02H /- 
\ 
m/z 353 m/z 249 
Scheme XIV 
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ion of lo-HOTrE (m/t 293) resulted in an ion at W/Z 
137 (Figure 6A and B, respectively). These fragment 
ions, which differ by 2 u, are consistent with fragmen- 
tation of the C-lO,C-11 bond in both compounds with 
loss of 45 u. The loss of 45 u involved loss of the 
carboxylate moiety because these ions were not shifted 
in the CID spectra of [‘sO,l-lO-HOTE and [‘80,1-10- 
HOTrE. Surprisingly, the additional loss of 1 u did not 
involve loss of the C-10 hydroxy proton via a charge- 
remote fragmentation (Scheme I) with C-10 proton 
transfer to C-13 because these ions were shifted to m/z 
136 and 138 in the CID spectra of the deuterated 
analogs. Possible mechanisms that lead to the forma- 
tion of these ions must account for the loss of both 
carboxylate oxygen atoms and retention of one ex- 
changeable deuterium atom and may involve prior 
rearrangement of the double bonds and transfer of a 
methylene hydrogen with fragmentation of the C-lO,C- 
11 bond. One proposed but unproven mechanism con- 
sistent with these requirements is shown in Scheme 
b 100 
I 
229 291 
165 I I 
293 
I 
Figure 6. Negative ion ES1 tandem mass spectrometry product 
ion spectra of (A) lo-hydroxy-4,6,8,12-octadecatetraenoic acid 
(lo-HOTE) ([M - HI-, tn/z 291) and (B) lo-hydroxy-4,6,12- 
octadecatrienoic acid (lo-HOTrE) ([M - HI-, w/z 293). 
Scheme XVI 
XVI for lo-HOTrE. The abundant ion at m/z 229 in the 
CID spectrum of lo-HOTE may be due to loss of Hz0 
and CO, and was not shifted in the CID spectrum of 
either [‘80,]10-HOTE or the deuterated analog. Loss 
of H,O may involve the C-10 hydroxy substituent and 
a proton at C-3, which results in formation of an 
extended tetraene system that starts at C-3. This would 
stabilize a C-2 anion formed by loss of CO,. Notably, 
the low mass ion at m/z 59 observed in the CID 
spectra of other metabolites was not observed in the 
CID spectra of these chain-shortened compounds. This 
was consistent with the location of the double bond at 
C-4 (see Scheme VI). 
5,12-Dihydroxy-6-Glttathionyl-7,9,14- 
Eicosatrienoic Acid (c-LTB,) and 5,12-Dihydroxy- 
6-Cysteinylglycyl-7,9,14-Eicosatrienoic Acid 
(d-LTB,) (Figure 7) 
The CID spectrum of c-LTB, was dominated by ions 
that resulted from fragmentation of the peptide moiety 
rather than a-hydroxy-type fragmentations. The abun- 
dant ions at m/z 272 and 254 (loss of Hz0 from m/z 
272) also were observed in the FAB-MS/MS spectrum 
of LTC, [29] and result from fragmentation at the 
sulfur atom with charge located at one of the carboxyl- 
ate positions in the peptide. The ion at m/z 143, which 
also was present in the CID spectrum of d-LTB,, could 
result from additional loss at the glutamic acid moiety. 
The CID spectrum of d-LTB, revealed an abundant ion 
(m/z 229) that resulted from cY-hydroxy fragmentation 
of the carbon-carbon backbone. After loss of the pep- 
tide group, this ion could result from either a charge- 
remote fragmentation of the C-lO,C-11 bond with hy- 
droxy proton transfer to C-9 and charge located at the 
carboxy terminus or a charge-driven fragmentation of 
the same bond initiated by a C-12 alkoxide ion. 
Conclusion 
Negative ion ES1 tandem mass spectrometry produced 
unique spectra for all LTB,-derived metabolites via 
routine use of l-5 ng of sample. Sensitivity levels were 
not optimized in the present study and the use of 
precolumn concentration and HPLC introduction of 
samples undoubtedly would provide greater sensitiv- 
ity for tandem mass spectrometry analysis. This may 
be particularly useful for identification of glutathione 
conjugates of LTB, which cannot be analyzed by 
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Figure 7. Negative ion ES1 tandem mass spectrometry product 
ion spectra of (A) 5,12-dihydroxy-6-glutathionyl-7,9,14- 
eicosatrienoic acid (c-LTB,) ([M - HI-, m/z 642) and (B) 5,12- 
dihydroxy-6-cysteinylglycyl-7,9,14-eicosatrienoic acid fd-LTB,) 
([M - HI-, 18/z 513). 
derivatization and GC/MS analysis. These metabolites 
previously could be analyzed only by FAB-MS/MS, 
which requires 40-100 ng of sample [HI. Also, analy- 
sis of other LTB,-derived metabolites by derivatization 
and GC/MS analysis required lo-50 ng for full struc- 
tural characterization via both negative and positive 
ion detection. 
Knowledge of the fragmentation processes de- 
scribed in the present study also may allow use of 
tandem mass spectrometry protocols such as parent 
ion scanning for the detection of LTB,-derived metabo- 
lites. This would be expected to result in an even 
greater gain in sensitivity. For example, a characteristic 
product ion at m/z 195 was indicative of LTB, and all 
metabolites of LTB, that were modified by methyl 
terminus metabolism. Also, reduction of one of the 
double bonds of the conjugated triene system resulted 
in an abundant product ion at m/z 115. CID mecha- 
nisms that result in the formation of these ions gener- 
ally are described by charge-remote or charge-directed 
J Am Sot Mass Spectrom 1996,7,129-139 
processes that involve the hydroxy substituent and a 
double bond two carbon atoms removed from the 
hydroxy-substituted carbon. For most of the fragmen- 
tations observed in the LTB,-derived metabolites, this 
requires double bond rearrangement prior to fragmen- 
tation. Rearrangement of the conjugated triene system 
to a cyclohexadiene structure previously has been sug- 
gested [22, 231 and is consistent with the gas chro- 
matography behavior of these compounds. In the pres- 
ent study, this rearrangement apparently does not 
differentiate double bond stereochemistry as was ob- 
served in the thermal rearrangement. Rearrangement 
of a conjugated diene also was suggested in GC/MS 
analysis [201. This rearrangement was supported in the 
present study by the nearly identical spectra obtained 
for 6,7-dihydro-LTB, and lO,ll-dihydro-LTB,. For 
these structures, the use of less abundant ions may be 
necessary for structural characterization. 
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